Short-term safety of adjuvant nivolumab therapy after neoadjuvant docetaxel plus cisplatin and 5-FU therapy for locally advanced esophageal squamous cell carcinoma.

被引：0
|
作者：
Hirose, Toshiharu
Yamamoto, Shun
Kadono, Toru
Ikeda, Go
Ohara, Akihiro
Itoyama, Mai
Yokoyama, Kazuki
Honma, Yoshitaka
Ishiyama, Koshiro
Oguma, Junya
Daiko, Hiroyuki
Kato, Ken
机构：
[1] Natl Canc Ctr, Dept Head & Neck, Esophageal Med Oncol, Tokyo, Japan
[2] Dept Esophageal Surg, Natl Canc Ctr Hosp, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
312
引用
收藏
页码：312 / 312
页数：1
相关论文
共 50 条
  • [1] Safety and short-term efficacy of adjuvant nivolumab after neoadjuvant docetaxel, cisplatin, and fluorouracil for locally advanced esophageal squamous cell carcinoma.
    Okunaka, Mashiro
    Kotani, Daisuke
    Sato, Kazuma
    Fujiwara, Naoto
    Mishima, Saori
    Shitara, Kohei
    Fujita, Takeo
    Kojima, Takashi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 271 - 271
  • [2] Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma
    Wing-Lok Chan
    Cheuk-Wai Choi
    Ian Yu-Hong Wong
    Terence Hon-Ting Tsang
    Adrian Tin-Chung Lam
    Rosa Pui-Ying Tse
    K. K. Chan
    Claudia Wong
    Betty Tze-Ting Law
    Emina Edith Cheung
    Siu-Yin Chan
    Ka-On Lam
    Dora Kwong
    Simon Law
    [J]. Annals of Surgical Oncology, 2023, 30 : 861 - 870
  • [3] Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma
    Chan, Wing-Lok
    Choi, Cheuk-Wai
    Wong, Ian Yu-Hong
    Tsang, Terence Hon-Ting
    Lam, Adrian Tin-Chung
    Tse, Rosa Pui-Ying
    Chan, K. K.
    Wong, Claudia
    Law, Betty Tze-Ting
    Cheung, Emina Edith
    Chan, Siu-Yin
    Lam, Ka-On
    Kwong, Dora
    Law, Simon
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (02) : 861 - 870
  • [4] The overall safety and short-term efficacy of nivolumab plus ipilimumab for advanced esophageal squamous cell carcinoma.
    Shiraishi, Kazuhiro
    Yamamoto, Shun
    Yoshinami, Yuri
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Kashiraha, Tairo
    Kurita, Daisuke
    Ishiyama, Koshiro
    Oguma, Junya
    Igaki, Hiroshi
    Daiko, Hiroyuki
    Kato, Ken
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 329 - 329
  • [5] Cetuximab plus chemoradiation with cisplatin and 5-fluorouracil (5-FU) in locally advanced unresectable esophageal squamous cell carcinoma.
    Sunpaweravong, P.
    Sunpaweravong, S.
    Sangthawan, D.
    Pinaikul, S.
    Attasaranya, S.
    Dechaphunkul, A.
    Mitarnun, W.
    Fungthammasarn, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable locally advanced esophageal squamous cell carcinoma
    Yoshinami, Y.
    Yamamoto, S.
    Shiraishi, K.
    Itoyama, M.
    Imazeki, H.
    Yokoyama, K.
    Honma, Y.
    Kurita, D.
    Ishiyama, K.
    Oguma, J.
    Daiko, H.
    Kato, K.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 : S168 - S168
  • [7] Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.
    Yoshinami, Yuri
    Yamamoto, Shun
    Kadono, Toru
    Hirose, Toshiharu
    Ikeda, Go
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Ishiyama, Koshiro
    Oguma, Junya
    Daiko, Hiroyuki
    Kato, Ken
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 373 - 373
  • [8] Neoadjuvant triplet chemotherapy with docetaxel, cisplatin plus 5-FU vs docetaxel, cisplatin plus S-1 for advanced esophageal squamous cell carcinoma: Propensity score matched analysis
    Kitadani, Junya
    Ojima, Toshiyasu
    Hayata, Keiji
    Goda, Taro
    Takeuchi, Akihiro
    Tominaga, Shinta
    Fukuda, Naoki
    Nakai, Tomoki
    Yamaue, Hiroki
    Kawai, Manabu
    [J]. ONCOLOGY, 2024, 102 (03) : 228 - 238
  • [9] Neoadjuvant chemotherapy using concurrent Docetaxel/CDDP/5-FU (DCF) in esophageal squamous cell carcinoma and its short-term prognosis
    Natsuya Katada
    Keishi Yamashita
    Chikatoshi Katada
    Hiromitsu Moriya
    Kei Hosoda
    Hiroaki Mieno
    Katsuhiko Higuchi
    Shoko Komori
    Hiromichi Ishiyama
    Kazushige Hayakawa
    Mitsuhiro Sugawara
    Satoshi Tanabe
    Wasaburo Koizumi
    Shiro Kikuchi
    Masahiko Watanabe
    [J]. Esophagus, 2014, 11 : 173 - 181
  • [10] Neoadjuvant chemotherapy using concurrent Docetaxel/CDDP/5-FU (DCF) in esophageal squamous cell carcinoma and its short-term prognosis
    Katada, Natsuya
    Yamashita, Keishi
    Katada, Chikatoshi
    Moriya, Hiromitsu
    Hosoda, Kei
    Mieno, Hiroaki
    Higuchi, Katsuhiko
    Komori, Shoko
    Ishiyama, Hiromichi
    Hayakawa, Kazushige
    Sugawara, Mitsuhiro
    Tanabe, Satoshi
    Koizumi, Wasaburo
    Kikuchi, Shiro
    Watanabe, Masahiko
    [J]. ESOPHAGUS, 2014, 11 (03) : 173 - 181
12345